176 related articles for article (PubMed ID: 31112291)
1. Statin use and risk of liver cancer: Evidence from two population-based studies.
Tran KT; McMenamin ÚC; Coleman HG; Cardwell CR; Murchie P; Iversen L; Lee AJ; Thrift AP
Int J Cancer; 2020 Mar; 146(5):1250-1260. PubMed ID: 31112291
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.
Tran KT; McMenamin ÚC; Hicks B; Murchie P; Thrift AP; Coleman HG; Iversen L; Johnston BT; Lee AJ; Cardwell CR
Aliment Pharmacol Ther; 2018 Jul; 48(1):55-64. PubMed ID: 29741272
[TBL] [Abstract][Full Text] [Related]
3. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
4. Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.
McGlynn KA; Hagberg K; Chen J; Graubard BI; London WT; Jick S; Sahasrabuddhe VV
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25722350
[TBL] [Abstract][Full Text] [Related]
5. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
6. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.
Vell MS; Loomba R; Krishnan A; Wangensteen KJ; Trebicka J; Creasy KT; Trautwein C; Scorletti E; Seeling KS; Hehl L; Rendel MD; Zandvakili I; Li T; Chen J; Vujkovic M; Alqahtani S; Rader DJ; Schneider KM; Schneider CV
JAMA Netw Open; 2023 Jun; 6(6):e2320222. PubMed ID: 37358849
[TBL] [Abstract][Full Text] [Related]
7. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
8. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
[TBL] [Abstract][Full Text] [Related]
9. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink.
Liu Z; Alsaggaf R; McGlynn KA; Anderson LA; Tsai HT; Zhu B; Zhu Y; Mbulaiteye SM; Gadalla SM; Koshiol J
Gut; 2019 Aug; 68(8):1458-1464. PubMed ID: 30448774
[TBL] [Abstract][Full Text] [Related]
10. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.
Thrift AP; Natarajan Y; Liu Y; El-Serag HB
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2117-2125.e3. PubMed ID: 30625400
[TBL] [Abstract][Full Text] [Related]
11. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
[TBL] [Abstract][Full Text] [Related]
12. Statin use and risk of hepatocellular carcinoma in a U.S. population.
McGlynn KA; Divine GW; Sahasrabuddhe VV; Engel LS; VanSlooten A; Wells K; Yood MU; Alford SH
Cancer Epidemiol; 2014 Oct; 38(5):523-7. PubMed ID: 25113938
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.
Chen CI; Kuan CF; Fang YA; Liu SH; Liu JC; Wu LL; Chang CJ; Yang HC; Hwang J; Miser JS; Wu SY
Medicine (Baltimore); 2015 Feb; 94(6):e462. PubMed ID: 25674734
[TBL] [Abstract][Full Text] [Related]
14. Statin use and survival in patients with gastric cancer in two independent population-based cohorts.
Spence AD; Busby J; Hughes CM; Johnston BT; Coleman HG; Cardwell CR
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):460-470. PubMed ID: 30456916
[TBL] [Abstract][Full Text] [Related]
15. Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study.
Tascilar K; Dell'Aniello S; Hudson M; Suissa S
Arthritis Rheumatol; 2016 Nov; 68(11):2603-2611. PubMed ID: 27273914
[TBL] [Abstract][Full Text] [Related]
16. Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
Liu P; McMenamin ÚC; Johnston BT; Murchie P; Iversen L; Lee AJ; Vissers PAJ; Cardwell CR
Br J Cancer; 2020 Jul; 123(2):307-315. PubMed ID: 32367073
[TBL] [Abstract][Full Text] [Related]
17. Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.
Spence AD; Busby J; Murchie P; Kunzmann AT; McMenamin ÚC; Coleman HG; Johnston BT; O'Rorke MA; Murray LJ; Iversen L; Lee AJ; Cardwell CR
Int J Cancer; 2018 Jul; 143(1):22-31. PubMed ID: 29396851
[TBL] [Abstract][Full Text] [Related]
18. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
19. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Cho Y; Kim MS; Nam CM; Kang ES
Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
[TBL] [Abstract][Full Text] [Related]
20. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.
Mamtani R; Lewis JD; Scott FI; Ahmad T; Goldberg DS; Datta J; Yang YX; Boursi B
PLoS Med; 2016 Apr; 13(4):e1002007. PubMed ID: 27116322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
